Saphnelo 300 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
7680685120014
CH-68512
Konzentrat
Associated product:
SAPHNELO conc perf 300 mg/2ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
anifrolumabum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
lysini hydrochloridum
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 990.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2022
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68512
- Drug name
- Saphnelo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AG11
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 31/08/2022
- Authorization expiration date
- 30/08/2027
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SAPHNELO conc perf 300 mg/2ml flac
- Description (DE)
- SAPHNELO Inf Konz 300 mg/2ml Durchstf
- Market launch
- 31/08/2022
- Narcotic (BTM)
- No